By mediating the coupled movement of Na, K, and Cl ions across the plasma membrane of most animal cells, the bumetanide-sensitive Na-K-Cl cotransporter (NKCC) plays a vital role in the regulation of ionic balance and cell volume. The transporter is a central element in the process of vectorial salt transport in secretory and absorptive epithelia. A cDNA encoding a Na-K-Cl cotransport protein was isolated from a shark rectal gland library by screening with monoclonal antibodies to the native shark cotransporter. The 1191-residue protein predicted from the cDNA sequence has 12 putative transmembrane domains flanked by large cytoplasmic N and C termini. Regulatory phosphoacceptor residues in isolated peptides are identified as Thr-189 and Thr-1114 The Na-K-Cl cotransporter (NKCC) operates in conjunction with the Na pump, a K channel, and a Cl channel to carry out transepithelial salt movement. In secretory epithelia, the importance of this system has been recently underscored by the discovery that mutations in the structure of the Cl-channel protein (CFT7R) comprise the defect in cystic fibrosis (1, 2). In an absorptive epithelium, the thick ascending limb of the loop of Henle in the mammalian kidney, the Na-K-Cl cotransporter is the target of the potent "loop diuretic" drugs furosemide and bumetanide (cf. ref. 3).The rectal gland of the dogfish shark is a model saltsecreting epithelium and is among the richest known sources of the Na-K-Cl cotransport protein (4); it has also been the subject of recent investigations of CFTR, K channels, and Na pumps (5-8). In the secretory cell, cotransporter activity appears to be regulated by the level ofintracellular Cl-through a process involving direct phosphorylation of the transport protein (9,10).We have previously prepared monoclonal antibodies to the shark rectal gland cotransporter, a 195-kDa glycosylated protein with a core molecular mass of -135 kDa (11). Here we report the cloning of a cDNA encoding the secretory Na-K-Cl cotransporter using these antibodies to screen a shark cDNA expression library. § A full-length cDNA has been used to direct the expression of the shark cotransporter in a mammalian cell line-the expressed protein is found to retain the low affinity for loop diuretics characteristic of the native shark protein. It is also shown that the expressed cotransporter is subject to regulation in response to ionic concentration changes in the foreign cells. MATERIALS AND METHODSIsolation of cDNA and Sequence Analysis. A cDNA library was prepared in AZAP II from 20 ,ug of poly(A)+-enriched shark (Squalus acanthias) rectal gland RNA using oligo(dT) and random primers (Stratagene custom library). Filter transfers of the plated library were screened using a mixture of antibodies J3 and J7, which recognize epitopes in the C-terminal half of the transport protein (11). Three overlapping clones (3B, 9C, 24A) were isolated in two rounds of plaque purification. An additional clone (16-2) was obtained by rescreening the library with the 1.4-kb EcoRI/EcoRI fr...

The Na-K-Cl cotransporter (NKCC) is present in most animal cells where it functions in cell volume homeostasis and epithelial salt transport. We developed six monoclonal antibodies (designated T4, T8, T9, T10, T12, and T14) against a fusion protein fragment encompassing the carboxy-terminal 310 amino acids of the human colonic NKCC. These T antibodies selectively recognized putative NKCC proteins in a diverse variety of animal tissues. Western blot analysis of membranes isolated from 23 types of cells identified single bands of immunoreactive protein ranging in mass from 146 to 205 kDa. The amount of immunoreactive protein detected in these cells correlated with loop diuretic binding site density. Proteins identified previously as Na-K-Cl cotransporters by loop diuretic photoaffinity labeling were mutually recognized by multiple T antibodies. Most of the T antibodies effectively immunoprecipitated the denatured form of the NKCC protein. Immunocytochemical studies on the rabbit parotid gland demonstrated that NKCC is restricted to the basolateral margin of the acinar cells and absent from the ducts, in accord with the central role of Na-K-Cl cotransport in chloride secretion. In the rabbit kidney, NKCC was localized to the apical membrane of thick ascending limb cells, consistent with its role in chloride reabsorption.

By moving chloride into epithelial cells, the Na-K-Cl cotransporter aids transcellular movement of chloride across both secretory and absorptive epithelia. Using cDNA probes from the recently identified elasmobranch secretory Na-K-Cl cotransporter (sNKCC1) (Xu, J. C., Lytle, C. Zhu, T. T., Payne, J. A., Benz, E., and Forbush, B., III (1994) Proc. Natl. Acad. Sci. 91, 2201-2205), we have identified the human homologue. By screening cDNA libraries of a human colonic carcinoma line, T84 cell, we identified a sequence of 4115 bases from overlapping clones. The deduced protein is 1212 amino acids in length, and analysis of the primary structure indicates 12 transmembrane segments. The primary structure is 74% identical to sNKCC1, 91% identical to a mouse Na-K-Cl cotransporter (mNKCC1), 58% identical to rabbit and rat renal Na-K-Cl cotransporters (NKCC2), and 43% identical to the thiazide-sensitive Na-Cl cotransporters from flounder urinary bladder and rat kidney. Similar to sNKCC1 and mNKCC1, the 5'-end of the human colonic cotransporter is rich in G + C content. Interestingly, a triple repeat (GCG)7 occurs within the 5'-coding region and contributes to a large alanine repeat (Ala15). Two sites for N-linked glycosylation are predicted on an extracellular loop between putative transmembrane segments 7 and 8. A single potential site for phosphorylation by protein kinase A is present in the predicted cytoplasmic C-terminal domain. Northern blot analysis revealed a 7.4-7.5-kilobase transcript in T84 cells and shark rectal gland and a approximately 7.2-kilobase transcript in mammalian colon, kidney, lung, and stomach. Metaphase spreads from lymphocytes were probed with biotin-labeled cDNA and avidin fluorescein (the cotransporter gene was localized to human chromosome 5 at position 5q23.3). Human embryonic kidney cells stably transfected with the full-length cDNA expressed a approximately 170-kDa protein recognized by anti-cotransporter antibodies. Following treatment with N-glycosidase F, the molecular mass of the expressed protein was similar to that predicted for the core protein from the cDNA sequence (132-kDa) and identical to that of deglycosylated T84 cotransporter (approximately 135-kDa). The stably transfected cells exhibited a approximately 15-fold greater bumetanide-sensitive 86Rb influx than control cells, and this flux required external sodium and chloride. Flux kinetics were consistent with an electroneutral cotransport of 1Na:1K:2Cl. Preincubation in chloride-free media was necessary to activate fully the expressed cotransporter, suggesting a [Cl]-dependent regulatory mechanism.

The effect of cytoplasmic Cl concentration ([Cl]i) on the activation state ([3H]benzmetanide binding rate) and phosphorylation state (32P incorporation) of the Na-K-Cl cotransporter was evaluated in secretory tubules isolated from the dogfish shark rectal gland. Reduction of [Cl]i at relatively constant cell volume (by removal of extracellular Cl or Na or by addition of bumetanide) increased cotransporter activation and phosphorylation. Raising extracellular K concentration ([K]o) from 4 to 80 mM, a maneuver that elevated [Cl]i above normal, reduced basal cotransport activity and rendered it entirely refractory to forskolin. High [K]o also blocked activation and phosphorylation in response to cell shrinkage, despite the fact that [Cl]i was already greatly elevated as a consequence of osmotic water loss. The phosphatase inhibitor calyculin A also promoted activation, but not in cells preexposed briefly to high [K]o. In summary, maneuvers than lower [Cl]i activate the cotransporter, whereas those that elevate [Cl]i (or prevent it from decreasing) block activation in response to secretory stimuli. Cell Cl appears to govern its own rate of entry via Na-K-Cl cotransport by impeding regulatory phosphorylation of the Na-K-Cl cotransport protein.

SUMMARYWe mapped the cellular and subcellular distribution of the Na-K-Cl co-transporter (NKCC) in the adult gerbil inner ear by immunostaining with a monoclonal antibody (MAb T4) generated against human colon NKCC. Heavy immunolabeling was seen in the basolateral plasma membrane of marginal cells in the stria vascularis and dark cells in the vestibular system. Subpopulations of fibrocytes in the cochlear spiral ligament and limbus and underlying the vestibular neurosensory epithelium also stained with moderate to strong intensity, apparently along their entire plasmalemma. Because MAb T4 recognizes both the basolateral secretory (NKCC1) and the apical absorptive (NKCC2) isoforms of the co-transporter, we employed reverse transcription and the polymerase chain reaction (RT-PCR) to explore isoform diversity in inner ear tissues. Using NKCC1 and NKCC2 isoform-specific PCR primers based on mouse and human sequences, only transcripts for NKCC1 were detected in the gerbil inner ear. The presence of abundant NKCC1 in the basolateral plasmalemma of strial marginal and vestibular dark cells confirms conclusions drawn from pharmacological and physiological data. The co-expression of NKCC1 and Na,K-ATPase in highly specialized subpopulations of cochlear and vestibular fibrocytes provides further evidence for their role in recycling K ϩ leaked or effluxed through hair cells into perilymph back to endolymph, as postulated in current models of inner ear ion homeostasis.

We examined the binding of [3H]benzmetanide, a potent inhibitor of Na-K-Cl cotransport, to secretory tubules isolated from dogfish shark rectal glands. Specific binding increased dramatically (from 3 to 40 pmol/mg protein) when the tubules were exposed to secretory stimuli [e.g., vasoactive intestinal peptide, adenosine, forskolin, and permeable adenosine 3',5'-cyclic monophosphate (cAMP) analogues]. Binding was also promoted by osmotically induced changes in cell volume; a 45% reduction in cell water content mimicked the effect of secretagogues on binding, whereas a 40% increase in cell water was only half as effective. Volume-responsive binding required extracellular sodium and chloride. The effect of cell shrinkage on binding was rapid and reversible (half-activation time = approximately 3 min, half-deactivation time = approximately 2 min). The binding sites evoked by secretagogues and by cell shrinkage had similar affinities for [3H]benzmetanide (Kd approximately 0.35 microM). Forskolin, a potent secretagogue, increased cell cAMP content 10-fold and respiration 7-fold, whereas hypertonicity affected neither parameter. The effects of cAMP-dependent stimuli and hypertonicity on binding were not additive. These results suggest the following. 1) Na-K-Cl cotransporters acquire the ability to bind [3H]benzmetanide with high affinity when activated. 2) Hormonal modulation of rectal gland secretion involves a coordinated regulation of basolateral Na-K-Cl cotransporters and apical Cl channels. 3) Separate signal transduction pathways, one sensitive to cAMP and another to cell volume, regulate the Na-K-Cl cotransporter.

Na-K-Cl cotransport activity in duck erythrocytes increases ϳ10-fold in response to osmotic cell shrinkage, norepinephrine, fluoride, or calyculin-A (an inhibitor of type-1 and -2a phosphatases). To assess whether all four stimuli promote phosphorylation of the cotransport protein and whether this phosphorylation is catalyzed by the same kinase, the cotransporter was isolated from erythrocytes by immunoprecipitation and its pattern of phosphorylation was evaluated. Each stimulus evoked proportionate increases in cotransporter activity and phosphorylation. No two stimuli in combination evoked greater activation and phosphorylation than did the more potent of the two stimuli acting alone. Phosphoamino acid analysis of the cotransport protein indicated that phosphorylation occurs at serine and threonine residues. Phosphopeptide mapping revealed a distinctive pattern of 8 major tryptic phosphopeptides, none of which were significantly phosphorylated in the unstimulated state. Maps of cotransporters activated by the four different stimuli were indistinguishable. Measurements of phosphorylation stoichiometry indicated that each cotransporter acquires ϳ5 phosphates on going from an inactive state in swollen cells to an active state in shrunken cells. Staurosporine, a kinase inhibitor with broad selectivity, inhibited each stimulus equipotently (IC 50 ϳ 0.7 M). Staurosporine promptly reversed cotransporter activity and phosphorylation when added to shrinkage-stimulated but not to calyculin-stimulated cells, indicating that it enters the cell rapidly and blocks phosphorylation. These results suggest that cell shrinkage, cAMP, fluoride, and calyculin-A promote the phosphorylation of the Na-K-Cl cotransport protein at a similar constellation of serine and threonine residues. It is proposed that all modes of stimulation ultimately involve the same protein kinase.Na-K-Cl cotransport is regulated by numerous first and second messengers through a complex and cell-specific interplay of stimulatory and inhibitory signals (1). The molecular mechanisms by which cell surface receptors, cell volume, cytosolic chloride, cytoskeletal architecture, and proliferative status modulate cotransport activity remain unknown. Early recognition that ion movement by the Na-K-Cl cotransporter, although energetically passive (2, 3), requires cytosolic ATP and Mg 2ϩ (2, 4 -7) prompted speculation that acute regulation might involve reversible phosphorylation of the cotransport protein, regulatory subunits, or upstream signal transducers (8, 9). Circumstantial support came from demonstrations that cotransport activity is increased by agents that inhibit protein phosphatases (10, 11) and decreased by agents that inhibit protein kinases (11,12). Recent studies have established that the Na-K-Cl cotransporter itself is a phosphoprotein (11, 13, 14) whose phosphorylation state parallels its activation state (13-18). While it is generally assumed that cotransporter phosphorylation is both necessary and sufficient for transport activity, recent research su...

No abstract